GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Purchase Of Investment

Greenyn Biotechnology Co (ROCO:6846) Purchase Of Investment : NT$-57.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Purchase Of Investment?

Greenyn Biotechnology Co's purchase of investment for the three months ended in Mar. 2024 was NT$-57.5 Mil. It means Greenyn Biotechnology Co spent NT$57.5 Mil on purchasing investments. Greenyn Biotechnology Co's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-57.5 Mil.

Compared with last quarter (NT$0.0 Mil in Dec. 2023 ), Greenyn Biotechnology Co spent more money on purchasing investments in Mar. 2024 (NT$-57.5 Mil).


Greenyn Biotechnology Co Purchase Of Investment Historical Data

The historical data trend for Greenyn Biotechnology Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Purchase Of Investment Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
- - -80.00 - -62.71

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -57.50

Greenyn Biotechnology Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-57.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenyn Biotechnology Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines